In 2023, the pancreas malignant neoplasms mortality in Brazil was recorded at 13.52 thousand deaths. From 2024 onwards, forecasted data shows a consistent upward trend in mortality rates. Year-on-year growth rates reveal steady increases with 3.29% in 2025, 3.19% in 2026, 3.02% in 2027, and 2.87% in 2028. The compound annual growth rate (CAGR) for the period from 2024 to 2028 stands at approximately 2.84%, indicating a persistent rise in mortality.
Future trends to watch for include the impact of healthcare advancements and lifestyle changes on mortality rates. Additionally, monitoring demographic shifts and healthcare policies will be crucial in understanding potential fluctuations in these forecasts.
